(Q37320751)

19 August 2017

1 reference

title

The tumour microenvironment: a novel target for cancer therapy (English)

1 reference

19 August 2017

E Hanna

1

1 reference

19 August 2017

J Quick

series ordinal

2

1 reference

19 August 2017

S K Libutti

series ordinal

3

1 reference

19 August 2017

publication date

1 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

15

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

8-17

1 reference

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2008.01471.X

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2008.01471.X

Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2008.01471.X

Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2008.01471.X

A phase I study of oral CC-5013 (lenalidomide, Revlimid), a thalidomide derivative, in patients with refractory metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2008.01471.X

10.1111/J.1601-0825.2008.01471.X

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference